Related Experiment Videos
Current therapy for thalassemia in Italy
1Department of Pediatrics, University of Turin, Italy.
Annals of the New York Academy of Sciences
|January 1, 1990
Summary
Italian thalassemia patient care has improved due to a national treatment protocol, standardized data recording (Computhal), and a national registry. Quality assurance (Cooley Care) and cooperative trials further enhanced outcomes.
Area of Science:
- Hematology
- Public Health
- Medical Informatics
Background:
- Thalassemia care in Italy has seen significant advancements.
- Cooperation among clinical centers has improved patient quality of life.
Purpose of the Study:
- To outline key factors contributing to improved thalassemia patient care in Italy.
- To highlight the impact of national initiatives on managing thalassemia.
Main Methods:
- Adoption of a national treatment protocol (since 1980) with regular updates.
- Implementation of standardized data recording and a computerized clinical record (Computhal).
- Establishment of a national registry for demographic and vital statistics.
- Development of a quality assurance program (Cooley Care) with key indicators and a central database.
- Conducting cooperative clinical trials and pilot studies on emerging issues like chelation therapy and drug pharmacokinetics.
Main Results:
- Improved care and quality of life for thalassemic patients in Italy.
- Data collection and analysis through national registry and Computhal system.
- Insights into disease pathology, complications, and causes of death from clinical trials.
- Investigation of intensive chelation, desferrioxamine (DFO) pharmacokinetics, and toxicity.
Conclusions:
- A multi-faceted national approach, including standardized protocols, data management, quality assurance, and research, has significantly enhanced thalassemia patient care in Italy.
- Addressing psychological and social aspects is crucial for comprehensive patient management.